Cann Group poised to scale-up production after securing A$8.2m from shareholders by Steve Jones December 5, 2022April 29, 2024 Cann Group has secured A$8.18 million from shareholders in its latest capital raise as the company […]
Bod strikes CBD over-the-counter deal with pharma firm Arrotex by Steve Jones December 2, 2022April 29, 2024
Avecho chief warns of placebo dangers as firms roll out CBD clinical trials by Steve Jones October 20, 2022April 29, 2024
Wellnex warns of ‘limited shelf space’ as firm lays groundwork for OTC launch by Steve Jones October 6, 2022April 29, 2024
Company news: Emyria; Ananda Wellness; InhaleRx; Cann Global; HFA by Steve Jones September 28, 2022April 29, 2024
Ecofibre launches low-cost CBD product and pins hope on OTC market to drive profitability by Steve Jones August 23, 2022April 29, 2024
Over-the-counter sales to create ‘most significant opportunity in years’ says Ecofibre boss by Steve Jones August 3, 2022April 29, 2024
Bod’s S3 registration candidate to go on sale through Special Access Scheme by Steve Jones June 27, 2022April 29, 2024
Over-the-counter race hots up as Cann Group prepares to recruit patients for sleep disturbance trial by Steve Jones February 16, 2022April 29, 2024
